FGF-BP2 Polyclonal Antibody

FGFBP2 (fibroblast growth factor binding protein 2) encodes a member of the fibroblast growth factor binding protein family. The encoded protein is a serum protein that is selectively secreted by cytotoxic lymphocytes and may be involved in cytotoxic lymphocyte-mediated immunity. An increase in the amount of gene product may be associated with atopic asthma and mild extrinsic asthma.

The FGF-BP2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of FGF-BP2 protein in various biological samples. This antibody has been meticulously developed using advanced techniques to ensure exceptional performance and reliability.

The FGF-BP2 Polyclonal Antibody exhibits a high affinity towards FGF-BP2 protein, enabling accurate and precise measurement of its expression levels. It has been extensively validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

This antibody is produced using state-of-the-art recombinant technology, ensuring batch-to-batch consistency and minimizing any potential variability. It has been rigorously tested to ensure minimal cross-reactivity with other proteins, ensuring specificity and accuracy in experimental results.

The FGF-BP2 Polyclonal Antibody is supplied as a liquid formulation, making it convenient and easy to use. It is provided in a ready-to-use format, eliminating the need for any additional preparation steps. The antibody is stable and can be stored at -20°C, allowing for long-term storage without compromising its performance.

With its exceptional sensitivity, specificity, and reliability, the FGF-BP2 Polyclonal Antibody is an invaluable tool for researchers studying FGF-BP2 protein and its role in various biological processes. Its high-quality performance and ease of use make it an ideal choice for both basic research and clinical applications.